Moosmann A - Search Results

1

Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.

Rancan C, Schirrmann L, Hüls C, Zeidler R, Moosmann A. Rancan C, et al. Among authors: moosmann a. PLoS Pathog. 2015 Jun 11;11(6):e1004906. doi: 10.1371/journal.ppat.1004906. eCollection 2015 Jun. PLoS Pathog. 2015. PMID: 26067064 Free PMC article.

2

B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells.

Moosmann A, Khan N, Cobbold M, Zentz C, Delecluse HJ, Hollweck G, Hislop AD, Blake NW, Croom-Carter D, Wollenberg B, Moss PA, Zeidler R, Rickinson AB, Hammerschmidt W. Moosmann A, et al. Blood. 2002 Sep 1;100(5):1755-64. Blood. 2002. PMID: 12176897 Free article.

3

Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines.

Wiesner M, Zentz C, Hammer MH, Cobbold M, Kern F, Kolb HJ, Hammerschmidt W, Zeidler R, Moosmann A. Wiesner M, et al. Among authors: moosmann a. Eur J Immunol. 2005 Jul;35(7):2110-21. doi: 10.1002/eji.200425936. Eur J Immunol. 2005. PMID: 15971271 Free article.

4

Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.

Hettich E, Janz A, Zeidler R, Pich D, Hellebrand E, Weissflog B, Moosmann A, Hammerschmidt W. Hettich E, et al. Among authors: moosmann a. Gene Ther. 2006 May;13(10):844-56. doi: 10.1038/sj.gt.3302714. Gene Ther. 2006. PMID: 16421600

5

Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.

Adhikary D, Behrends U, Moosmann A, Witter K, Bornkamm GW, Mautner J. Adhikary D, et al. Among authors: moosmann a. J Exp Med. 2006 Apr 17;203(4):995-1006. doi: 10.1084/jem.20051287. Epub 2006 Mar 20. J Exp Med. 2006. PMID: 16549597 Free PMC article.

6

COX-inhibitors relieve the immunosuppressive effect of tumor cells and improve functions of immune effectors.

Lang S, Picu A, Hofmann T, Andratschke M, Mack B, Moosmann A, Gires O, Tiwari S, Zeidler R. Lang S, et al. Among authors: moosmann a. Int J Immunopathol Pharmacol. 2006 Apr-Jun;19(2):409-19. doi: 10.1177/039463200601900217. Int J Immunopathol Pharmacol. 2006. PMID: 16831307 Free article.

7

Activated B cells mediate efficient expansion of rare antigen-specific T cells.

Zentz C, Wiesner M, Man S, Frankenberger B, Wollenberg B, Hillemanns P, Zeidler R, Hammerschmidt W, Moosmann A. Zentz C, et al. Among authors: moosmann a. Hum Immunol. 2007 Feb;68(2):75-85. doi: 10.1016/j.humimm.2006.12.004. Epub 2007 Jan 8. Hum Immunol. 2007. PMID: 17321896

8

Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition.

Lang S, Tiwari S, Andratschke M, Loehr I, Lauffer L, Bergmann C, Mack B, Lebeau A, Moosmann A, Whiteside TL, Zeidler R. Lang S, et al. Among authors: moosmann a. Cancer Immunol Immunother. 2007 Oct;56(10):1645-52. doi: 10.1007/s00262-007-0312-5. Epub 2007 Mar 27. Cancer Immunol Immunother. 2007. PMID: 17387473 Free PMC article.

9

Conditional immortalization of human B cells by CD40 ligation.

Wiesner M, Zentz C, Mayr C, Wimmer R, Hammerschmidt W, Zeidler R, Moosmann A. Wiesner M, et al. Among authors: moosmann a. PLoS One. 2008 Jan 23;3(1):e1464. doi: 10.1371/journal.pone.0001464. PLoS One. 2008. PMID: 18213373 Free PMC article.

10

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.

Moosmann A, Bigalke I, Tischer J, Schirrmann L, Kasten J, Tippmer S, Leeping M, Prevalsek D, Jaeger G, Ledderose G, Mautner J, Hammerschmidt W, Schendel DJ, Kolb HJ. Moosmann A, et al. Blood. 2010 Apr 8;115(14):2960-70. doi: 10.1182/blood-2009-08-236356. Epub 2010 Jan 26. Blood. 2010. PMID: 20103780 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page